Cargando…

Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol

INTRODUCTION: Globally, transgender and other gender diverse (trans) people face pervasive stigma, which contributes to health inequities across multiple health outcomes. Stigma is a fundamental cause of health inequities because it simultaneously limits access to resources, contributes to systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanner, Amanda E, Goldenberg, Tamar, Erausquin, Jennifer Toller, Mertus, Sulianie, Jibriel, Mohammed Sheikh Eldin, Barrington, Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263898/
https://www.ncbi.nlm.nih.gov/pubmed/35798529
http://dx.doi.org/10.1136/bmjopen-2022-061691
_version_ 1784742851767173120
author Tanner, Amanda E
Goldenberg, Tamar
Erausquin, Jennifer Toller
Mertus, Sulianie
Jibriel, Mohammed Sheikh Eldin
Barrington, Clare
author_facet Tanner, Amanda E
Goldenberg, Tamar
Erausquin, Jennifer Toller
Mertus, Sulianie
Jibriel, Mohammed Sheikh Eldin
Barrington, Clare
author_sort Tanner, Amanda E
collection PubMed
description INTRODUCTION: Globally, transgender and other gender diverse (trans) people face pervasive stigma, which contributes to health inequities across multiple health outcomes. Stigma is a fundamental cause of health inequities because it simultaneously limits access to resources, contributes to systemic vulnerability and generates chronic stress. Anti-trans stigma occurs across multiple socioecological levels, resulting in multiple possible definitions and measurements of trans stigma. Understanding how trans stigma has been measured in low-income and middle-income countries (LMICs) is critical to health promotion efforts for trans communities. Accordingly, this scoping review will identify and examine how anti-trans stigma has been measured in existing LMIC-specific research to inform best practices for measurement of anti-trans stigma that includes consideration of local context. METHODS AND ANALYSIS: This is the protocol for a scoping review of anti-trans stigma in LMICs. We will search (from January 2001 to December 2021) PubMed, WHO Global Medicus and EBSCO. Study selection will conform to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. Original studies in English, Spanish, Arabic or Russian will be included. Reviewers will independently screen all citations, full-text articles and abstract data. Data analysis will involve quantitative and qualitative methods. A narrative summary of findings will be conducted. ETHICS AND DISSEMINATION: As a scoping review (no direct interaction with participants), this study is exempt from human subjects oversight. Understanding context-specific ways to measure anti-trans stigma is urgently needed to support trans health globally. The planned scoping review will help to address this gap. Results of the review will be disseminated in a peer-reviewed journal and likely in other media such as conferences, seminars and symposia. PROTOCOL REGISTRATION NUMBER: osf.io/qcs2v
format Online
Article
Text
id pubmed-9263898
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-92638982022-07-25 Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol Tanner, Amanda E Goldenberg, Tamar Erausquin, Jennifer Toller Mertus, Sulianie Jibriel, Mohammed Sheikh Eldin Barrington, Clare BMJ Open Public Health INTRODUCTION: Globally, transgender and other gender diverse (trans) people face pervasive stigma, which contributes to health inequities across multiple health outcomes. Stigma is a fundamental cause of health inequities because it simultaneously limits access to resources, contributes to systemic vulnerability and generates chronic stress. Anti-trans stigma occurs across multiple socioecological levels, resulting in multiple possible definitions and measurements of trans stigma. Understanding how trans stigma has been measured in low-income and middle-income countries (LMICs) is critical to health promotion efforts for trans communities. Accordingly, this scoping review will identify and examine how anti-trans stigma has been measured in existing LMIC-specific research to inform best practices for measurement of anti-trans stigma that includes consideration of local context. METHODS AND ANALYSIS: This is the protocol for a scoping review of anti-trans stigma in LMICs. We will search (from January 2001 to December 2021) PubMed, WHO Global Medicus and EBSCO. Study selection will conform to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. Original studies in English, Spanish, Arabic or Russian will be included. Reviewers will independently screen all citations, full-text articles and abstract data. Data analysis will involve quantitative and qualitative methods. A narrative summary of findings will be conducted. ETHICS AND DISSEMINATION: As a scoping review (no direct interaction with participants), this study is exempt from human subjects oversight. Understanding context-specific ways to measure anti-trans stigma is urgently needed to support trans health globally. The planned scoping review will help to address this gap. Results of the review will be disseminated in a peer-reviewed journal and likely in other media such as conferences, seminars and symposia. PROTOCOL REGISTRATION NUMBER: osf.io/qcs2v BMJ Publishing Group 2022-07-07 /pmc/articles/PMC9263898/ /pubmed/35798529 http://dx.doi.org/10.1136/bmjopen-2022-061691 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Public Health
Tanner, Amanda E
Goldenberg, Tamar
Erausquin, Jennifer Toller
Mertus, Sulianie
Jibriel, Mohammed Sheikh Eldin
Barrington, Clare
Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol
title Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol
title_full Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol
title_fullStr Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol
title_full_unstemmed Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol
title_short Measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol
title_sort measuring anti-transgender stigma in low-income and middle-income countries: a scoping review protocol
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263898/
https://www.ncbi.nlm.nih.gov/pubmed/35798529
http://dx.doi.org/10.1136/bmjopen-2022-061691
work_keys_str_mv AT tanneramandae measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol
AT goldenbergtamar measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol
AT erausquinjennifertoller measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol
AT mertussulianie measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol
AT jibrielmohammedsheikheldin measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol
AT barringtonclare measuringantitransgenderstigmainlowincomeandmiddleincomecountriesascopingreviewprotocol